patent.fyi
Applications  /  US 2026/0355417
United States Patent Application Publication

US 2026/0355417 A1

Published
Nov 12, 2026
Filed
Oct 25, 2023
Earliest date on the face
Sep 19, 2023
Classification
A61M 5/1723
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Fingerstick readings at intervals

What ifWhat if the controller receives blood glucose readings from fingerstick tests at discrete times?
Claim language“continuously detect a blood glucose value”

A handheld meter measures glucose in a capillary blood sample with a disposable electrochemical strip and sends the result with its timestamp. The controller updates its estimate when a reading arrives and uses a preset basal schedule when the most recent reading exceeds a configured age limit.

1.2Breath actuated powder delivery

What ifWhat if the patient takes inhaled insulin at meals and uses a separate long acting basal injection?
Claim language“infuse insulin into the patient”

The controller displays a meal dose in cartridge increments, and the patient loads the indicated dry powder cartridge into a breath actuated inhaler. Inhalation disperses the powder into the lungs, where insulin enters the bloodstream. A separate long acting injection supplies basal insulin.

1.3Independent sensor and pump control

What ifWhat if the sensor manages its own measurements and broadcasts glucose readings to a controller that commands only the pump?
Claim language“control the detection mechanism and the infusion mechanism”

A sensor microcontroller sets its sampling interval, converts electrode current to a glucose estimate, and broadcasts a timestamped reading. The pump controller receives the broadcast through a one-way link, computes an infusion instruction, and drives the pump motor.

1.4Meal detection from glucose trends

What ifWhat if the controller starts the meal function when it detects a sustained rise in glucose?
Claim language“an input from the patient”

The controller computes a glucose slope over a rolling window and checks whether the slope exceeds a threshold across successive samples. When the trigger criteria are met, the controller adjusts delivery subject to limits on active insulin and the programmed maximum delivery rate.

1.4Meal dosing by carbohydrate grams

What ifWhat if the patient enters grams of carbohydrate and the controller uses one calculation for all meal sizes?
Claim language“a high carbohydrate mode and a normal carbohydrate mode”

A numeric entry field supplies carbohydrate grams to a calculator that divides the entry by the stored grams-per-unit ratio. The calculator applies a glucose correction, accounts for active insulin, and rounds the result to the pump's delivery increment.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Closed-loop feeding trials in veterinary research

A veterinary research station connects a continuous glucose sensor and a subcutaneous insulin pump to a controller assigned to one animal. The handler selects the normal or high carbohydrate mode on a console when serving a measured ration. The controller combines the selected mode with the animal's glucose readings, applies the configured infusion limits, and logs feeding times, glucose readings, and confirmed insulin delivery.

Component substitution

Stepper-driven syringe for insulin infusion

A motorized syringe driver replaces the infusion mechanism and connects an insulin reservoir to a subcutaneous infusion line. A stepper motor turns a lead screw that advances the syringe plunger, and the driver converts each requested volume to a step count using a stored calibration for the syringe size. A position encoder checks plunger travel, and a force sensor detects excessive resistance. The driver reports completed travel and delivery faults to the glucose controller, which retains the patient-selected meal mode.

Parameter or scale variation

One-minute and five-minute controller scheduling

A controller reads the latest glucose sample and its timestamp every 60 seconds and stores up to 30 minutes of readings. It evaluates the infusion instruction every 5 minutes using the glucose trend, confirmed delivery history, and the patient-selected normal or high carbohydrate mode. Each instruction carries a sequence number and expires after 5 minutes, and the pump rejects expired or previously processed instructions. The controller enters its configured sensor-loss state if the latest glucose sample is more than 10 minutes old.

Combination with existing systems

Meal mode linked to tray records

A bedside glucose controller receives meal records from a hospital dietary management system through a local network interface. Each record contains a patient identifier, a tray identifier, and the estimated carbohydrate content of the served portions. After matching the tray and patient identifiers, the interface displays the carbohydrate estimate beside the normal and high carbohydrate mode controls. The patient confirms a mode at the start of the meal, and the controller uses that mode, the confirmation timestamp, and continuous glucose readings to generate infusion instructions.

Automated or data-driven variant

Meal mode suggestion from portion weights

A kitchen scale sends tared portion weights to an application that stores digestible carbohydrate per gram for foods selected by the patient. The application multiplies each portion weight by its stored carbohydrate value and sums the results for the meal. It compares the sum with a patient-specific threshold and displays either the normal or high carbohydrate mode for confirmation. The glucose controller uses the confirmed mode with current glucose readings and confirmed insulin delivery history to calculate its next instruction.

Meal response estimation from glucose history

A controller stores patient-confirmed meal modes and timestamps alongside continuous glucose readings and pump-confirmed delivery records. Software fits separate post-meal glucose response profiles for normal and high carbohydrate meals using historical intervals with complete sensor and delivery data. At the next confirmed meal, the controller loads the profile for the selected mode and uses it with current glucose and active insulin estimates to forecast glucose for the infusion calculation. The controller uses a preset profile whenever the selected mode has insufficient usable history.

Specific version of a part

External meal command terminal

The standalone terminal displays meal options and sends the selection with a timestamp and sequence number over a short-range radio link. The pump controller checks the message, rejects stale or repeated commands, and applies the corresponding meal parameters.

Enzyme coated glucose electrode

A subcutaneous filament carries a glucose oxidase working electrode, a reference electrode, and a counter electrode. The sensor measures current at a fixed working potential and converts the signal to an estimated blood glucose value at five-minute intervals.

Lead screw syringe pump

A stepper motor turns a lead screw that advances the plunger of an insulin cartridge. The controller meters delivery by counting motor steps, and a flexible tube carries insulin from the cartridge to a subcutaneous cannula.

Predictive insulin delivery controller

The controller uses recent glucose measurements and recorded insulin delivery to predict glucose over a fixed time horizon. At each update, it computes a delivery rate within programmed bounds and sends the pump an instruction for the next control interval.

Two preset meal selections

A touchscreen displays high carbohydrate and normal carbohydrate selections, each linked to a stored carbohydrate estimate. After the patient confirms a selection, the controller uses the associated estimate, the current glucose value, and active insulin to calculate a meal infusion instruction.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 8,096,983 B2
Published
Jan 17, 2012
Filed
Mar 7, 2006
Class
A61M 31/00
Document BUS 2021/0353857 A1
Published
Nov 18, 2021
Filed
May 18, 2021
Class
A61M 5/1723
Claim 1
Document A
Document B
1.1a detection mechanism, configured to continuously detect a blood glucose value of a patient;
A CGM provides a substantially continuous estimated blood glucose level through a transcutaneous sensor that estimates blood analyte levels, such as blood glucose levels, via the patient's interstitial fluid CGM systems typically consist of a transcutaneously-placed sensor, a transmitter and a monitor.
B · US 2021/0353857 A1 · ¶ 5
1.2an infusion mechanism, configured to infuse insulin into the patient;
The continuous subcutaneous insulin infusion pump is an apparatus having an insulin reservoir and a pump for infusion of insulin and is employed for continuously and subcutaneously infusing insulin to a via an infusion tube.
A · US 8,096,983 B2 · ¶ 26
Some insulin injecting pumps are configured as portable or ambulatory infusion devices can provide continuous subcutaneous insulin injection and/or infusion therapy as an alternative to multiple daily injections of insulin via a syringe or an insulin pen.
B · US 2021/0353857 A1 · ¶ 4
1.3a program mechanism, configured to control the detection mechanism and the infusion mechanism, and at least based on the blood glucose value detected by the detection mechanism, the program mechanism generates an insulin infusion instruction and controls the infusion mechanism to perform the infusion, wherein:
The apparatus generally includes therein a clock and a program which allows the infusion rate to be changed at predetermined intervals.
A · US 8,096,983 B2 · ¶ 26
1.4the program mechanism comprises a user interface, and in response to an input from the patient, the program mechanism performs a meal mode function, which corresponds to the input, the meal mode comprises a high carbohydrate mode and a normal carbohydrate mode.
At the meal time, the program allows each patient to be infused an additional amount of insulin.
A · US 8,096,983 B2 · ¶ 26
In some AID systems, a user can manually inform the algorithm that the user will be eating in what is often referred to as a “meal announcement.” In response to a meal announcement, the algorithm will typically increase the basal rate being delivered to the user in anticipation of increased blood glucose levels due to the consumption of carbohydrates in the meal.
B · US 2021/0353857 A1 · ¶ 8

An empty cell means only that no passage was reproduced there.

Statements in these documents
However, there has not been established algorithm for optimizing the temporal change in insulin infusion rate of a CSII pump for individual patients, and in general the infusion rate is empirically determined by the attending physician.
A · US 8,096,983 B2 · ¶ 4
Thus, an object of the present invention is to provide means for optimizing the insulin infusion rate of a CSII pump for each patient.
A · US 8,096,983 B2 · ¶ 5
As noted above, insulin or other medicament dosing by basal rate and/or bolus techniques could automatically be provided by a pump based on readings received into the pump from a CGM device that is, e.g., external to the portable insulin pump or integrated with the pump as a pump-CGM system in a closed-loop or semi-closed-loop fashion.
B · US 2021/0353857 A1 · ¶ 7
However, increasing the basal rate in response to a meal announcement can subject the user to undesirable oscillations in glucose levels because the timing and amount of carbohydrates that will be consumed may be unknown.
B · US 2021/0353857 A1 · ¶ 8
Cite aspatent.fyi, US 2026/0355417 A1, claim 1, first published 2026-11-19T11:55:28-05:00, https://patent.fyi/US20260355417/, SHA-256 811065798a4e29b38f4951a7e805f9fce90ec0e48aac9122ce29b2ced23d009d
First published
Permanent addresshttps://patent.fyi/US20260355417/
Content fingerprint (SHA-256)811065798a4e29b38f4951a7e805f9fce90ec0e48aac9122ce29b2ced23d009d
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi